Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biomedicines|May 16, 2023
Fecal and Urinary Adipokines as Disease BiomarkersHauke C Tews, Tanja Elger, Thomas Grewal, et al.
Frontiers in Medicine|November 28, 2022
Urinary chemerin as a potential biomarker for inflammatory bowel diseaseStefan Gunawan, Tanja Elger, Johanna Loibl, et al.
Journal of Clinical Medicine|August 14, 2025
Decline in Serum Lysophosphatidylcholine Species in Patients with Severe Inflammatory Bowel DiseaseHauke Christian Tews, Tanja Elger, Muriel Huss, et al.
International Journal of Molecular Sciences|May 11, 2024
Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing CholangitisGanimete Bajraktari, Tanja Elger, Muriel Huss, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 18, 2024
Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitisSilke Matysik, Tanja Elger, Muriel Huss, et al.
Biomedicines|January 8, 2025
Fecal Nervonic Acid as a Biomarker for Diagnosing and Monitoring Inflammatory Bowel DiseaseClaudia Kunst, Tanja Elger, Johanna Loibl, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 23, 2025
Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel DiseaseAngelika Hettenbach, Tanja Elger, Muriel Huss, et al.
International Journal of Molecular Sciences|May 14, 2025
Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease SeverityMuriel Huss, Tanja Elger, Claudia Kunst, et al.
Frontiers in Medicine|February 13, 2025
Interprofessional approach to personalized medication management and therapy optimization in IBD careDaniel Fleischmann, Benedicta Binder, Muriel Huss, et al.
Pageof 2